Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2034

1.

LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells.

Hirano K, Takada Y, Furukawa K.

Histochem Cell Biol. 2019 Oct 12. doi: 10.1007/s00418-019-01822-3. [Epub ahead of print]

PMID:
31606752
2.

In vitro assembly and cellulolytic activity of a β-glucosidase-integrated cellulosome complex.

Hirano K, Saito T, Shinoda S, Haruki M, Hirano N.

FEMS Microbiol Lett. 2019 Oct 4. pii: fnz209. doi: 10.1093/femsle/fnz209. [Epub ahead of print]

PMID:
31584652
3.

GWAS with principal component analysis identifies a gene comprehensively controlling rice architecture.

Yano K, Morinaka Y, Wang F, Huang P, Takehara S, Hirai T, Ito A, Koketsu E, Kawamura M, Kotake K, Yoshida S, Endo M, Tamiya G, Kitano H, Ueguchi-Tanaka M, Hirano K, Matsuoka M.

Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21262-21267. doi: 10.1073/pnas.1904964116. Epub 2019 Sep 30.

4.

Clinical Impact and Predictors of the Slow-Flow Phenomenon after Endovascular Treatment of Infrapopliteal Lesions Using the Crosser Catheter in Patients with Critical Limb Ischemia.

Kobayashi N, Hirano K, Yamawaki M, Araki M, Sakai T, Sakamoto Y, Mori S, Tsutsumi M, Nauchi M, Honda Y, Makino K, Shirai S, Sugizaki Y, Fukagawa T, Kishida T, Ito Y.

J Vasc Interv Radiol. 2019 Sep 18. pii: S1051-0443(19)30548-2. doi: 10.1016/j.jvir.2019.05.034. [Epub ahead of print]

PMID:
31542277
5.

Management of Postoperative Inflammation and Dry Eye After Cataract Surgery.

Kato K, Miyake K, Hirano K, Kondo M.

Cornea. 2019 Nov;38 Suppl 1:S25-S33. doi: 10.1097/ICO.0000000000002125.

PMID:
31498249
6.

Comparison of urea clear space and eKt/V during online hemodiafiltration.

Nakayama T, Kawauchi R, Hirano K.

Clin Nephrol. 2019 Sep 9. doi: 10.5414/CN109781. [Epub ahead of print] No abstract available.

PMID:
31496511
7.

Prior physical synchrony enhances rapport and inter-brain synchronization during subsequent educational communication.

Nozawa T, Sakaki K, Ikeda S, Jeong H, Yamazaki S, Kawata KHDS, Kawata NYDS, Sasaki Y, Kulason K, Hirano K, Miyake Y, Kawashima R.

Sci Rep. 2019 Sep 4;9(1):12747. doi: 10.1038/s41598-019-49257-z.

8.

Risk of undiagnosed coronary artery disease associated with infrapopliteal artery occlusion from a multicenter study.

Imaeda S, Kuno T, Hirano K, Kodaira M, Anzai H, Numasawa Y.

Heart Vessels. 2019 Aug 31. doi: 10.1007/s00380-019-01495-x. [Epub ahead of print]

PMID:
31473802
9.

Insulin secretion improvement during steroid therapy for autoimmune pancreatitis according to the onset of diabetes mellitus.

Noguchi K, Nakai Y, Mizuno S, Isayama H, Hirano K, Kanai S, Nakamura T, Uchino R, Takahara N, Kogure H, Tada M, Koike K.

J Gastroenterol. 2019 Aug 30. doi: 10.1007/s00535-019-01615-4. [Epub ahead of print]

PMID:
31471733
10.

Development of a simultaneous quantitation for short-, medium-, long-, and very long-chain fatty acids in human plasma by 2-nitrophenylhydrazine-derivatization and liquid chromatography-tandem mass spectrometry.

Chen Z, Gao Z, Wu Y, Shrestha R, Imai H, Uemura N, Hirano KI, Chiba H, Hui SP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Sep 15;1126-1127:121771. doi: 10.1016/j.jchromb.2019.121771. Epub 2019 Aug 19.

PMID:
31465896
11.

A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402).

Yokoyama T, Yoshioka H, Fujimoto D, Demura Y, Hirano K, Kawai T, Kagami R, Washio Y, Ishida T, Kogo M, Tomii K, Okuno T, Akai M, Hirabayashi M, Nishimura T, Nakahara Y, Kim YH, Miyakoshi C, Yoshimura K, Hirai T; Kyoto Thoracic Oncology Research Group (KTORG).

Lung Cancer. 2019 Sep;135:175-180. doi: 10.1016/j.lungcan.2019.03.030. Epub 2019 Mar 28.

PMID:
31446992
12.

Neuroprotective effects of memantine via enhancement of autophagy.

Hirano K, Fujimaki M, Sasazawa Y, Yamaguchi A, Ishikawa KI, Miyamoto K, Souma S, Furuya N, Imamichi Y, Yamada D, Saya H, Akamatsu W, Saiki S, Hattori N.

Biochem Biophys Res Commun. 2019 Oct 8;518(1):161-170. doi: 10.1016/j.bbrc.2019.08.025. Epub 2019 Aug 17.

PMID:
31431260
13.

Helical assembly of a dithienogermole exhibiting switchable circularly polarized luminescence.

Hirano K, Ikeda T, Fujii N, Hirao T, Nakamura M, Adachi Y, Ohshita J, Haino T.

Chem Commun (Camb). 2019 Aug 29;55(71):10607-10610. doi: 10.1039/c9cc05253d.

PMID:
31424063
14.

Characterization of fructooligosaccharide-degrading enzymes in human commensal Bifidobacterium longum and Anaerostipes caccae.

Tanno H, Fujii T, Ose R, Hirano K, Tochio T, Endo A.

Biochem Biophys Res Commun. 2019 Oct 15;518(2):294-298. doi: 10.1016/j.bbrc.2019.08.049. Epub 2019 Aug 13.

PMID:
31420164
15.

Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).

Tamiya M, Tamiya A, Hosoya K, Taniguchi Y, Yokoyama T, Fukuda Y, Hirano K, Matsumoto H, Kominami R, Suzuki H, Hirashima T, Uchida J, Morita M, Kanazu M, Sawa N, Kinoshita Y, Hara S, Kumagai T, Fujimoto D.

Invest New Drugs. 2019 Aug 7. doi: 10.1007/s10637-019-00843-y. [Epub ahead of print]

PMID:
31392549
16.

Visualization of sequential conversion of human intermediately reprogrammed stem cells into iPS cells.

Teshigawara R, Hirano K, Nagata S, Huang D, Tada T.

Genes Cells. 2019 Oct;24(10):667-673. doi: 10.1111/gtc.12716. Epub 2019 Sep 1.

PMID:
31386786
17.

Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan.

Edahiro R, Kanazu M, Kurebe H, Mori M, Fujimoto D, Taniguchi Y, Suzuki H, Hirano K, Yokoyama T, Morita M, Fukuda Y, Uchida J, Makio T, Tamiya M.

PLoS One. 2019 Jul 31;14(7):e0220570. doi: 10.1371/journal.pone.0220570. eCollection 2019.

18.

Impact of kestose supplementation on the healthy adult microbiota in in vitro fecal batch cultures.

Endo A, Hirano K, Ose R, Maeno S, Tochio T.

Anaerobe. 2019 Jul 19:102076. doi: 10.1016/j.anaerobe.2019.102076. [Epub ahead of print]

PMID:
31326442
19.

What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness.

Sekiguchi N, Hamano A, Kitagawa T, Ito K, Hirano K, Yamada K.

Blood Res. 2019 Jun;54(2):153-156. doi: 10.5045/br.2019.54.2.153. Epub 2019 Jun 25. No abstract available.

20.

[Are the Medical Staff Ready to Respond to the Suffering from Sexuality of Terminal Cancer Patients ?]

Kusakabe A, Hirano K, Mawatari H, Morita C, Nara T, Kessoku T, Matsuura T, Yoshimi A, Gotou A, Inamori M, Ohta M.

Gan To Kagaku Ryoho. 2019 May;46(Suppl 1):57-59. Japanese.

PMID:
31189855
21.

Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder.

Li M, Hirano KI, Ikeda Y, Higashi M, Hashimoto C, Zhang B, Kozawa J, Sugimura K, Miyauchi H, Suzuki A, Hara Y, Takagi A, Ikeda Y, Kobayashi K, Futsukaichi Y, Zaima N, Yamaguchi S, Shrestha R, Nakamura H, Kawaguchi K, Sai E, Hui SP, Nakano Y, Sawamura A, Inaba T, Sakata Y, Yasui Y, Nagasawa Y, Kinugawa S, Shimada K, Yamada S, Hao H, Nakatani D, Ide T, Amano T, Naito H, Nagasaka H, Kobayashi K; Japan TGCV study group.

Orphanet J Rare Dis. 2019 Jun 11;14(1):134. doi: 10.1186/s13023-019-1087-4.

22.

Copper-Catalyzed Electrophilic Amination of gem-Diborylalkanes with Hydroxylamines Providing α-Aminoboronic Acid Derivatives.

Nishino S, Hirano K, Miura M.

Org Lett. 2019 Jun 21;21(12):4759-4762. doi: 10.1021/acs.orglett.9b01640. Epub 2019 Jun 5.

PMID:
31184168
23.

Detection of Jordans' anomaly using compact-type automated hematology analyzer.

Inaba T, Okumura K, Fujita N, Suzuki A, Hirano KI.

Int J Hematol. 2019 Aug;110(2):129-130. doi: 10.1007/s12185-019-02689-9. Epub 2019 Jun 10. No abstract available.

PMID:
31183815
24.

Association Between Tonsillectomy and Outcomes in Patients With Immunoglobulin A Nephropathy.

Hirano K, Matsuzaki K, Yasuda T, Nishikawa M, Yasuda Y, Koike K, Maruyama S, Yokoo T, Matsuo S, Kawamura T, Suzuki Y.

JAMA Netw Open. 2019 May 3;2(5):e194772. doi: 10.1001/jamanetworkopen.2019.4772.

25.

A randomized-controlled trial of early endotherapy versus wait-and-see policy for mild symptomatic pancreatic stones in chronic pancreatitis.

Saito T, Nakai Y, Mizuno S, Isayama H, Sasahira N, Watanabe T, Matsubara S, Arizumi T, Togawa O, Hirano K, Tsujino T, Ishigaki K, Hakuta R, Saito K, Takahara N, Hamada T, Kogure H, Tada M, Koike K.

Eur J Gastroenterol Hepatol. 2019 Aug;31(8):979-984. doi: 10.1097/MEG.0000000000001457.

PMID:
31149913
26.

Involvement of different receptor subtypes in prostaglandin E2-induced contraction and relaxation in the lower esophageal sphincter and esophageal body.

Bai X, Ihara E, Otsuka Y, Tsuruta S, Hirano K, Tanaka Y, Ogino H, Hirano M, Chinen T, Akiho H, Nakamura K, Oda Y, Ogawa Y.

Eur J Pharmacol. 2019 Aug 15;857:172405. doi: 10.1016/j.ejphar.2019.172405. Epub 2019 May 22.

PMID:
31128092
27.

Synthesis of α-Trifluoromethylamines by Cu-Catalyzed Regio- and Enantioselective Hydroamination of 1-Trifluoromethylalkenes.

Takata T, Hirano K, Miura M.

Org Lett. 2019 Jun 7;21(11):4284-4288. doi: 10.1021/acs.orglett.9b01471. Epub 2019 May 13.

PMID:
31082241
28.

Comparison of functional glycans between cancer stem cells and normal stem cells.

Sasaki N, Itakura Y, Gomi F, Hirano K, Toyoda M, Ishiwata T.

Histol Histopathol. 2019 Sep;34(9):995-1007. doi: 10.14670/HH-18-119. Epub 2019 Apr 26. Review.

PMID:
31025698
29.

Alkynylboration Reaction Leading to Boron-Containing π-Extended cis-Stilbenes as a Highly Tunable Fluorophore.

Nogami M, Hirano K, Morimoto K, Tanioka M, Miyamoto K, Muranaka A, Uchiyama M.

Org Lett. 2019 May 3;21(9):3392-3395. doi: 10.1021/acs.orglett.9b01132. Epub 2019 Apr 18.

PMID:
30997806
30.

Fibrin-associated diffuse large B-cell lymphoma arising in a mature cystic teratoma: A case report.

Yorita K, Tanaka Y, Hirano K, Mizobuchi M, Kohno K, Nakamura S, Sakaeda H.

Pathol Int. 2019 May;69(5):312-314. doi: 10.1111/pin.12788. Epub 2019 Apr 12. No abstract available.

PMID:
30977946
31.

Gas/Liquid-Phase Micro-Flow Trifluoromethylation using Fluoroform: Trifluoromethylation of Aldehydes, Ketones, Chalcones, and N-Sulfinylimines.

Hirano K, Gondo S, Punna N, Tokunaga E, Shibata N.

ChemistryOpen. 2019 Feb 5;8(4):406-410. doi: 10.1002/open.201800286. eCollection 2019 Apr.

32.

Gas/Liquid-Phase Micro-Flow Trifluoromethylation using Fluoroform: Trifluoromethylation of Aldehydes, Ketones, Chalcones, and N-Sulfinylimines.

Hirano K, Gondo S, Punna N, Tokunaga E, Shibata N.

ChemistryOpen. 2019 Mar 12;8(4):402. doi: 10.1002/open.201900070. eCollection 2019 Apr.

33.

Diaryl-λ3-chloranes: Versatile Synthesis and Unique Reactivity as Aryl Cation Equivalent.

Nakajima M, Miyamoto K, Hirano K, Uchiyama M.

J Am Chem Soc. 2019 Apr 24;141(16):6499-6503. doi: 10.1021/jacs.9b02436. Epub 2019 Apr 16.

PMID:
30969759
34.

Comparison of 12-month angiographic outcomes between repeat drug-eluting stent implantation and drug-coated balloon treatment for restenotic lesion caused by stent fracture.

Sakamoto Y, Yamawaki M, Araki M, Kobayashi N, Mori S, Tsutsumi M, Honda Y, Hirano K, Ito Y.

Heart Vessels. 2019 Oct;34(10):1589-1594. doi: 10.1007/s00380-019-01398-x. Epub 2019 Apr 8.

PMID:
30963303
35.

COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.

Nakai K, Karita S, Igarashi J, Tsukamoto I, Hirano K, Kubota Y.

J Dermatol Sci. 2019 Apr;94(1):205-212. doi: 10.1016/j.jdermsci.2019.02.003. Epub 2019 Mar 12.

PMID:
30954335
36.

Optimal imaging conditions for the diagnosis of pleuroperitoneal communication.

Nakayama T, Hashimoto K, Kiriyama T, Hirano K.

BMJ Case Rep. 2019 Mar 31;12(3). pii: e228940. doi: 10.1136/bcr-2018-228940.

37.

Hybrid Therapy for Mycotic Aortic Aneurysm with Stent-Graft and Video-Assisted Thoracoscopic Debridement.

Hirano K, Tokui T, Nakamura B, Inoue R, Inagaki M, Toyoshima H, Chino S, Watanabe F, Kato N, Maze Y.

Ann Vasc Dis. 2019 Mar 25;12(1):69-73. doi: 10.3400/avd.cr.18-00119.

38.

An Autopsy Case of Bing-Neel Syndrome: Discrepancy between the Radiological and Pathological Findings.

Matsuda S, Sekiguchi N, Ito K, Takaoka K, Furuki M, Hirano K, Obayashi M.

Intern Med. 2019 Jul 1;58(13):1947-1951. doi: 10.2169/internalmedicine.1907-18. Epub 2019 Mar 28.

39.

Trans-radial percutaneous coronary intervention for patients with severe chronic renal insufficiency and/or on dialysis.

Kuno T, Hirano K, Abe T, Imaeda S, Hashimoto K, Ryuzaki T, Yokokura S, Saito T, Yamazaki H, Tabei R, Kodaira M, Numasawa Y.

Heart Vessels. 2019 Sep;34(9):1412-1419. doi: 10.1007/s00380-019-01387-0. Epub 2019 Mar 22.

PMID:
30903313
40.

Negative impact of proteinuria on circulating myeloid dendritic cells.

Ikeda M, Terashima R, Yamada T, Suyama M, Yokote S, Nakao M, Yamamoto I, Hirano K, Okonogi H, Yamamoto H, Yokoo T.

Clin Exp Nephrol. 2019 Jul;23(7):928-938. doi: 10.1007/s10157-019-01724-7. Epub 2019 Mar 16.

41.

Intractable Coronary Artery Disease in a Patient With Type 2 Diabetes Presenting With Triglyceride Deposit Cardiomyovasculopathy.

Kozawa J, Higashi M, Shimomura I, Hirano KI.

Diabetes Care. 2019 May;42(5):983-986. doi: 10.2337/dc18-2365. Epub 2019 Mar 12. No abstract available.

PMID:
30862655
42.

Syndrome of inappropriate secretion of antidiuretic hormone associated with angiotensin-converting enzyme inhibitor therapy in the perioperative period.

Nakayama T, Fujisaki H, Hirai S, Kawauchi R, Ogawa K, Mitsui A, Hirano K, Isozumi K, Takahashi T, Komatsumoto S.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319834409. doi: 10.1177/1470320319834409.

43.

Synthesis of Seven-Membered Benzolactones by Nickel-Catalyzed C-H Coupling of Benzamides with Oxetanes.

Xu S, Takamatsu K, Hirano K, Miura M.

Chemistry. 2019 Jul 17;25(40):9400-9404. doi: 10.1002/chem.201900543. Epub 2019 Mar 19.

PMID:
30811060
44.

Antireflux covered metal stent for nonresectable distal malignant biliary obstruction: Multicenter randomized controlled trial.

Hamada T, Isayama H, Nakai Y, Iwashita T, Ito Y, Mukai T, Yagioka H, Saito T, Togawa O, Ryozawa S, Hirano K, Mizuno S, Yamamoto N, Kogure H, Yasuda I, Koike K.

Dig Endosc. 2019 Sep;31(5):566-574. doi: 10.1111/den.13381. Epub 2019 May 7.

PMID:
30803046
45.

Portal Vein Thrombosis in a Patient with Hereditary Antithrombin Deficiency.

Setaka T, Hirano K, Moriya K, Kaneko T, Morita S, Shinkai T, Morishita E, Ichida T.

Intern Med. 2019 Jun 15;58(12):1733-1737. doi: 10.2169/internalmedicine.2295-18. Epub 2019 Feb 25.

46.

Synthesis of Dibenzophospholes by Tf2O-Mediated Intramolecular Phospha-Friedel-Crafts-Type Reaction.

Nishimura K, Hirano K, Miura M.

Org Lett. 2019 Mar 1;21(5):1467-1470. doi: 10.1021/acs.orglett.9b00219. Epub 2019 Feb 14.

PMID:
30763103
47.

A Follow-Up from Infancy to Puberty in a Japanese Male with SRY-Negative 46,XX Testicular Disorder of Sex Development Carrying a p.Arg92Trp Mutation in NR5A1.

Saito-Hakoda A, Kanno J, Suzuki D, Kawashima S, Kamimura M, Hirano K, Sakai K, Igarashi M, Fukami M, Fujiwara I.

Sex Dev. 2019;13(2):60-66. doi: 10.1159/000496777. Epub 2019 Feb 9.

PMID:
30739115
48.

Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.

Iida O, Urasawa K, Komura Y, Soga Y, Inoue N, Hara H, Yajima J, Nakamura S, Ohki T, Ando H, Hirano K, Horita Y, Kichikawa K, Yokoi Y, Miyamoto A, Nakamura M, Takahara M, Mano T, Nanto S.

J Endovasc Ther. 2019 Apr;26(2):158-167. doi: 10.1177/1526602819826591. Epub 2019 Jan 31.

PMID:
30702021
49.

Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study.

Hirano K, Kobayashi D, Kohtani N, Uemura Y, Ohashi Y, Komatsu Y, Yanagita M, Hishida A.

Clin Exp Nephrol. 2019 May;23(5):613-620. doi: 10.1007/s10157-018-01684-4. Epub 2019 Jan 28.

50.

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review.

Imakita T, Matsumoto H, Hirano K, Morisawa T, Sakurai A, Kataoka Y.

BMC Cancer. 2019 Jan 25;19(1):105. doi: 10.1186/s12885-019-5309-x.

Supplemental Content

Loading ...
Support Center